Sucralose, the sugar substitute in many diet products, may weaken cancer immunotherapy by altering gut bacteria and reducing arginine levels needed for immune cells. But supplementation with arginine or citrulline could counteract this effect, pointing to new clinical trial possibilities.
Sucralose, the sugar substitute in many diet products, may weaken cancer immunotherapy by altering gut bacteria and reducing arginine levels needed for immune cells. But supplementation with arginine or citrulline could counteract this effect, pointing to new clinical trial possibilities. Sucralose, the sugar substitute in many diet products, may weaken cancer immunotherapy by altering gut bacteria and reducing arginine levels needed for immune cells. But supplementation with arginine or citrulline could counteract this effect, pointing to new clinical trial possibilities.